European ICU Sedation Drugs Market: Size, Trends & Forecasts (2017-2021) - PowerPoint PPT Presentation

Loading...

PPT – European ICU Sedation Drugs Market: Size, Trends & Forecasts (2017-2021) PowerPoint presentation | free to download - id: 87da90-MWVlM



Loading


The Adobe Flash plugin is needed to view this content

Get the plugin now

View by Category
About This Presentation
Title:

European ICU Sedation Drugs Market: Size, Trends & Forecasts (2017-2021)

Description:

The report entitled “European ICU Sedation Drugs Market: Size, Trends & Forecasts (2017-2021)”, provides analysis of Europe ICU sedation drugs market. – PowerPoint PPT presentation

Number of Views:14

less

Write a Comment
User Comments (0)
Transcript and Presenter's Notes

Title: European ICU Sedation Drugs Market: Size, Trends & Forecasts (2017-2021)


1
Europe ICU Sedation Drugs Market Size, Trends
Forecasts (2017-2021)
August 2017
2
Europe ICU Sedation Drugs Market Report
Scope of the Report The report entitled Europe
ICU Sedation Drugs Market Size, Trends
Forecasts (2017-2021), provides analysis of
Europe ICU sedation drugs market, with detailed
analysis of market size and growth, and
segmentation of the industry. The analysis of the
Europe ICU sedation drugs market includes the
market by value and by segments. Moreover, the
report also assesses the key opportunities in the
market and outlines the factors that are and will
be driving the growth of the industry. Growth of
the overall the Europe ICU sedation drugs market
has also been forecasted for the years 2017-2021,
taking into consideration the previous growth
patterns, the growth drivers and the current and
future trends. Aspen Pharmacare, Perrigo, Orion
Corporation and Primex Pharmaceuticals are some
of the key players operating in the Europe ICU
sedation drugs market, whose company profiling
has been done in the report. In this segment of
the report, business overview, financial overview
and business strategies of the companies are
provided. Company Coverage Aspen
Pharmacare Perrigo Orion Corporation Primex
Pharmaceuticals
3
Europe ICU Sedation Drugs Market Report
Executive Summary Sedation is described as the
action of reducing apprehension, stress,
irritability or excitement by administration of a
sedative agent or drug. A sedative is a
medication that commonly induces into
nervous system to calm and to relax.
Significantly, sedation is utilized as a part of
minor surgeries like dentistry, some corrective
surgeries or to deal with high tension patients.
Sedation is accomplished along a continuum of
sedation levels minimal sedation, moderate
sedation, deep sedation and general anesthesia.
The pathway by which a medicine or liquid is
entered into the body is called as route of
administration. Sedatives are administered
through various medium namely inhalation,
tablets, injections, or Intravenous (IVs).
Commonly used route of administration are
Intravenous (IVs) and Inhalation. An intravenous
route used a venipuncture as a means of injecting
central nervous system depressants into the
bloodstream. The major intravenous anesthetic
drugs are Remifentanil, Midazolam, Propofol and
Dexmedetomidine An inhalational sedation uses
inhalable route of administration, through an
anesthesia mask, laryngeal mask
airway or tracheal tube connected to
an anesthetic and an anesthetic delivery system
like AnaConDa and Mirus. The major inhalational
sedation or anesthetic agents that uses inhalable
route of administration are Sevoflurane,
Isoflurane and Desflurane. The Europe ICU
sedation drugs market is expected to increase at
high growth rates during the forecasted period
(2017-2021). The Europe ICU sedation drugs market
is supported by various growth drivers, rising
geriatric population, adoption of sedentary
lifestyle, increasing number of surgeries,
increasing healthcare expenditure, etc. Some
challenges that hinder the growth are adverse
effects of sedative drugs, lack of trained
healthcare providers and environmental issues,
etc.
4
The value of ICU sedation drugs market in Europe
was US... million in 2016, indicating an
increase as compared to US...million in 2015.
The ICU sedation drugs market is anticipated to
reach to US... million in 2021, as compared to
US.... million in 2017. Europe ICU sedation
drugs market is estimated to grow at a CAGR of
over the forecasted period 2017 to 2021. The ICU
sedation drugs market in Europe can be fragmented
into segments on the basis of drugs used for
sedation such as..
Europe ICU Sedation Drugs Market Overview
  • Europe ICU Sedation Drugs Market by Value
    2013-2016 (US Million)
  • Europe ICU Sedation Drugs Market by Value
    2017-2021 (US Million)
  • Europe ICU Sedation Drugs Market by Segment
    2016-2017

5
Europe ICU Sedation Drugs Market Segments Overview
  • Europe Dexmedetomidine ICU Sedation Drugs Market
    by Value 2013-2016(US Million)

Europe Propofol ICU Sedation Drug Market by Value
  • Europe Remifentanil ICU Sedation Drugs Market by
    Value 2013-2016 (US Million)

The dexmedetomidine drug market was US.. million
in 2016, increasing from US.. million in 2015.
The market depicted a growth at a CAGR of over
2013-2016 years. The Remifentanil drug market
value was US... million in 2016.
6
Title European ICU Sedation Drugs Market Size,
Trends Forecasts (2017-2021) Published August
2017 Pages 56 Price US 800 (Single-User
License) US 1600 (Corporate
License) For more Info http//www.daedal-researc
h.com//european-icu-sedation-drugs-market-size-tre
nds-forecasts-2017-2021
For more details please contact Mr. Rajeev Kumar
Tel 91-120-4553017 (9.30 am - 6.30 pm)
ISTMobile 91-8743975789 (24 X7)Enquiries
info_at_daedal-research.com
Daedal Research Daedal Research is a research and
consulting firm specialized in providing research
reports and customized business research and
analysis. The research firm offers a blend of the
best strategic consulting and market research
solutions, which promise data rich, cost
effective, and highly insightful analysis to help
its clients with perfect answers to their
important business queries.
About PowerShow.com